An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

October 18, 2017

Study Completion Date

April 18, 2018

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Investigational sIPV

Three intramuscular injections of the investigational vaccine (0.5 ml) on Day 0, Day 30 and Day 60 respectively; Single intramuscular injection of the investigational vaccine (0.5 ml) at 18 months; Intervention: investigational sIPV

BIOLOGICAL

Control IPV

Three intramuscular injections of the control vaccine (0.5 ml) on Day 0, Day 30 and Day 60 respectively; Single intramuscular injection of the control vaccine (0.5 ml) at 18 months; Intervention:control IPV

Trial Locations (1)

221300

Pizhou County Center for Disease Control and Prevention, Pizhou

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT03526978 - An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants | Biotech Hunter | Biotech Hunter